Sort
82,697 grants matching “vaccine development”
Defining the protective efficacy of antibodies against the EBV gH/gL glycoprotein complex
$763,782Andrew McGuire · Fred Hutchinson Cancer Center · R01 · FY2023 · AI
Functional genomic analysis of the CD8 T cell response to HIV vaccines in
$763,750William Nicholas Haining · Dana-Farber Cancer Inst · R01 · FY2010 · AI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome
$763,732Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
Novel Nanoparticle Respiratory Tract Mucosal Vaccine
$763,709Frederick D Quinn · University Of Georgia · R33 · FY2025 · AI
BKV and JCV vaccine development
$763,673Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Molecular biology of human polyomaviruses
$763,673Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Tethering lentiviral restriction to Fc-mediated antibody responses
$763,634David T Evans · University Of Wisconsin-Madison · R01 · FY2024 · AI
Tetravalent dengue vaccine based on complex adenovirus vectors
$763,587Kanakatte Raviprakash · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2010 · AI
Conjugate vaccine impact on pneumococcal carriage, disease, and population geneti
$763,538Jonathan A Finkelstein · Harvard Pilgrim Health Care, Inc. · R01 · FY2014 · AI
Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)
$763,534Casey Koontz · Leidos, Inc. · N01 · FY2017 · AI
Structural Studies of Human Papillomavirus
$763,513Susan Hafenstein · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · AI
Enhancing Discovery of HIV Host Genetics using Drug Abuse and other Interactions
$763,511Eric O Johnson · Research Triangle Institute · R01 · FY2014 · DA
Role of IgE in human disease and immunity to ticks
$763,421Scott Alan Smith · Vanderbilt University Medical Center · R01 · FY2024 · AI
Innate and early B cell responses to V. cholerae
$763,387Jason B Harris · Massachusetts General Hospital · R01 · FY2016 · AI
Assessment of vaccine/microbicide combination efficacy in the macaque model
$763,269Cecilia C Cheng-Mayer · Aaron Diamond Aids Research Center · R01 · FY2008 · AI
Production of Cross-Neutralizing HIV-1 Antibodies from Single B Cells
$763,162Miroslaw K Gorny · New York University School Of Medicine · R56 · FY2011 · AI
Improved protein-based meningococcal serogroup B vaccines
$763,136Peter T. Beernink · University Of California, San Francisco · R01 · FY2020 · AI
VACCINE PRODUCTION FACILITY
$763,126Univ Of Massachusetts Med Sch Worcester · N01 · FY2000 · AI
Immunobiology of Pediatric Tumors
$763,115Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Elucidation of Assembly and Budding Mechanisms of SARS-CoV-2
$763,024Robert Virgil Stahelin · Purdue University · R01 · FY2025 · AI
Discovery and development of novel HCMV inhibitors
$762,983Ravit Boger · Medical College Of Wisconsin · R56 · FY2025 · AI
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults
$762,973John F Alcorn · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
A Mucosal Vaccine for HSV-2
$762,971Kejian Yang · Biomedical Research Models, Inc. · R44 · FY2011 · AI
Epitope focusing by molecular grafting of subdominant epitopes to achieve a universal-influenza vaccine
$762,966Aaron Gregory Schmidt · Massachusetts General Hospital · R01 · FY2023 · AI
Epitope focusing by molecular grafting of subdominant epitopes to achieve a universal-influenza vaccine
$762,966Aaron Gregory Schmidt · Massachusetts General Hospital · R01 · FY2021 · AI